AŁAndrzej Łabyk

Andrzej Łabyk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andrzej Łabyk has a total of 57 co-authors. Here are the top co-authors by number of shared publications:

  • Piotr Pruszczyk

    Med Univ Warsaw, Dept Internal Med & Cardiol, 4 Lindleya St, Warsaw, Poland

    4 shared publications
  • Piotr Pruszczyk

    Department of Internal Medicine and Cardiology, Medical University of Warsaw , Warsaw

    4 shared publications
  • Barbara Lichodziejewska

    Med Univ Warsaw, Dept Internal Med & Cardiol, 4 Lindleya St, Warsaw, Poland

    3 shared publications
  • Marek Roik

    Med Univ Warsaw, Dept Internal Med & Cardiol, 4 Lindleya St, Warsaw, Poland

    3 shared publications
  • Marek Roik

    Med Univ Warsaw, Dept Internal Med & Cardiol, Ul Lindleya 4, PL-02005 Warsaw, Poland

    3 shared publications
  • Szymon Pacho

    Department of Internal Medicine and Cardiology with the Center for Management of Venous Thromboembolic Disease, Medical University of Warsaw, Warsaw, Poland

    3 shared publications

Latest Publications

  • Open Access

    Characteristics and Outcomes of Pulmonary Embolism Patients Transferred After Activation of Pulmonary Embolism Response Team and Admitted from Local Emergency Department

    by Mateusz Jermakow, Michał Machowski, Magdalena Gałecka-Nowak, Karol Deutsch, Adam Il, Anna M. Imiela, Bartosz Karolak, Katarzyna Perzanowska-Brzeszkiewicz, Szymon Pacho, Agnieszka Wójcik, et al.

    Background: The primary role of a pulmonary embolism response team (PERT) is to support decision-making processes regarding acute pulmonary embolism (PE) patients and provide advanced rescue therapies when needed. Despite a great need for its availability among physicians, PERT’s usefulness is yet to be proven. Objectives: Our goal was to establish whether patients benefit from qualification by PERT for admission to a tertiary cardiology ward. Methods: Data of all patients hospitalized due to PE for 12 months (July 2023–June 2024) were retrospectively analyzed. We aimed to compare patients admitted primarily via the emergency department with those consulted by PERT and eventually transferred from other hospitals. The primary outcome was the use of advanced therapies. Results: We identified 167 patients (50.3% women) hospitalized with PE. Out of them, 102 (61.1%) came from the emergency department, while 65 (38.9%) patients were transferred after PERT consultation. The transferred patients generally had more severe conditions, as indicated by the ESC death risk group classification (intermediate-high and high risk, OR 19.2, 95% CI 8.3–44.2). They were more often qualified for at least one of the advanced therapies than the emergency department patients (OR 23.2, 95% CI 9.3–58.1). We found no significant differences in in-hospital mortality (6.9% versus 1.5%, OR 4.7, 95% CI 0.6–39.3). Conclusions: Establishing PERT as a reference unit providing advanced treatment resulted in successfully delivering more complex treatment to severely ill PE patients. Despite their unfavorable basic characteristics, neither length of hospitalization nor in-hospital mortality seem to differ when compared to unselected, less compromised cases.


  • Open Access

    Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Department

    by Michał Machowski, Aisha Ou-Pokrzewińska, Katarzyna Perzanowska-Brzeszkiewicz, Magdalena Gałecka-Nowak, Szymon Pacho, Mateusz Jermakow, Agnieszka Wójcik, Milena Zoruk, Andrzej Pruszczyk, Karol Deutsch, et al.

    Background: COVID-19 increases the risk of acute cardiovascular diseases (CVDs), including acute coronary syndrome (ACS), acute pulmonary embolism (APE), and acute myocarditis (AMyo). The actual impact of CVDs on mortality of patients with COVID-19 remains unknown. This study aimed to determine whether CVDs influence the course of COVID-19 pneumonia and if they can be easily detected by using common tests and examinations. Material/Methods: Data of 249 consecutive patients with COVID-19 hospitalized in a dedicated cardiology department were analyzed. On admission, clinical status, biomarkers, computed tomography, and bedside echocardiography were performed. Results: D-dimer level predicted APE (AUC=0.850 95% CI [0.765; 0.935], P <0.001) with sensitivity of 69.4% and specificity of 96.2% for a level of 4968.0 ng/mL, and NT-proBNP predicted AMyo (AUC=0.692 95% CI [0.502; 0.883], P =0.004) and showed sensitivity of 54.5%, with specificity of 86.5% for the cut-off point of 8970 pg/mL. Troponin T levels were not useful for diagnostic differentiation between CVDs. An extent of lung involvement predicted mortality (OR=1.03 95% CI [1.01;1.04] for 1% increase, P <0.001). After adjusting for lung involvement, ACS increased mortality, compared with COVID-19 pneumonia only (OR=5.27 95% CI [1.76; 16.38] P =0.003), while APE and AMyo did not affect risk for death. Conclusions: D-dimer and NT-proBNP, but not troponin T, are useful in differentiating CVDs in patients with COVID-19. ACS with COVID-19 increased in -hospital mortality independently from extent of lung involvement, while coexisting APE or AMyo did not.


  • Open Access

    Refined balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension – reference center experience

    by Andrzej Łabyk, Marcin Krakowian, Łukasz Mysiorski, Barbara Lichodziejewska, Olga Dzikowska-Diduch, Aisha Ou-Pokrzewińska, Dariusz Zieliński, Marek Gołębiowski, Piotr Pruszczyk, Marek Roik

    Introduction: Chronic thromboembolic pulmonary hypertension (CTEPH), characterized by thromboembolic changes affecting the pulmonary bed, leads to ventricular function deterioration and premature death. The introduction of balloon pulmonary angioplasty (BPA) has significantly improved the...


  • Open Access

    Three-dimensional rotational angiography in diagnosis of chronic thromboembolic pulmonary hypertension

    by Michał A. Potępa, Andrzej Łabyk, Dariusz Zieliński, Piotr Pruszczyk, Marek Roik

    Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease resulting from stenosis or obstruction of the pulmonary arteries due to organized thrombus with disruption of blood flow and derivative microvascular remodelling in 4% of survivors of acute pulmonary embolism (PE). Computed...

  • Open Access

    One-day experience of pulmonary embolism response team (PERT) during the COVID-19 pandemic: three urgent percutaneous pulmonary embolectomies in acute pulmonary embolism

    by Andrzej Łabyk, Michał Potępa, Mateusz Jermakow, Michał Machowski, Piotr Pruszczyk, Marek Roik

    Percutaneous pulmonary embolectomy (PPE) is a rapidly evolving therapy in selected acute pulmonary embolism (APE) patients [1–5]. Novel percutaneous procedures tend not to be common, even in reference centers.


  • Open Access

    Initial experience of pulmonary embolism response team with percutaneous embolectomy in intermediate–high- and high-risk acute pulmonary embolism

    by Marek Roik, Dominik Wretowski, Andrzej Łabyk, Michał Ciurzyński, Katarzyna Kurnicka, Barbara Lichodziejewska, Szymon Pacho, Michał Potępa, Agnieszka Szramowska, Janusz Trzebicki, et al.


  • Open Access

    Balloon pulmonary angioplasty – efficient therapy of chronic thromboembolic pulmonary hypertension in the patient with advanced sarcoidosis – a case report

    by Andrzej Labyk, Dominik Wretowski, Sabina Zybińska-Oksiutowicz, Aleksandra Furdyna, Katarzyna Ciesielska, Dorota Piotrowska-Kownacka, Olga Dzikowska –Diduch, Barbara Lichodziejewska, Andrzej Biederman, Piotr Pruszczyk, et al.

    Approximately a quarter of patients with advanced sarcoidosis develop pulmonary hypertension (PH), which affects their prognosis. We report unusual case of confirmed chronic thromboembolic pulmonary hypertension (CTEPH) in a patient with stage IV sarcoidosis successfully treated with balloon pulmonary angioplasty (BPA). A 65 years old male with a history of colitis ulcerosa, and pulmonary sarcoidosis diagnosed in 10 years before, on long term oral steroids, with a history of deep vein thrombosis and acute pulmonary embolism chronically anticoagulated was referred to our center due to severe dyspnea. On admission he presented WHO functional class IV, mean pulmonary artery pressure (mPAP) in right heart catheterization (RHC) was elevated to 54 mmHg. Diagnosis of CTEPH was definitely confirmed with typical V/Q scan, and with selective pulmonary angiography (PAG) completes by intravascular imagining (intravascular ultrasound, optical coherent tomography). The patient was deemed inoperable by CTEPH team and two sessions of BPA with multimodal approach resulted in significant clinical and haemodynamical improvement to WHO class II and mPAP decrease to 27 mmHg. Balloon pulmonary angioplasty, rapidly developing method of treatment of inoperable CTEPH patients, is also extremely useful therapeutic tool in complex PH patients.


  • Electrocardiographic Differentiation between Acute Pulmonary Embolism and Non‐ST Elevation Acute Coronary Syndromes at the Bedside

    by Krzysztof Jankowski, Maciej Kostrubiec, Patrycja Ozdowska, Blanka Milanowska‐Puncewicz, Szymon Pacho, Justyna Pedowska‐Włoszek, Anna Kaczyńska, Andrzej Łabyk, Anna Hrynkiewicz, Piotr Pruszczyk

    Background: Clinical picture of acute pulmonary embolism (APE), with wide range of electrocardiographic (ECG) abnormalities can mimic acute coronary syndromes. Objectives: Assessment of standard 12‐lead ECG usefulness in differentiation at the bedside between APE and non‐ST elevation acute coronary syndrome (NSTE‐ACS). Methods: Retrospective analysis of 143 patients: 98 consecutive patients (mean age 63.4 ± 19.4 year, 45 M) with APE and 45 consecutive patients (mean age 72.8 ± 10.8 year, 44 M) with NSTE‐ACS. Standard ECGs recorded on admission were compared in separated groups. Results: Right bundle branch block (RBBB) and S1S2S3 or S1Q3T3 pattern were found in similar frequency in both groups (10 [11%] APE patients vs 6 [14%] NSTE‐ACS patients, 27 [28%] patients vs 7 [16%] patients, respectively, NS). Negative T waves in leads V1‐3 together with negative T waves in inferior wall leads II, III, aVF (OR 1.3 [1.14–1.68]) significantly indicated APE with a positive predictive value of 85% and specificity of 87%. However, counterclockwise axis rotation (OR 4.57 [2.74–7.61]), ventricular premature beats (OR 2.60 [1.60–4.19]), ST depression in leads V1‐3 (OR 2.25 [1.43–3.56]), and negative T waves in leads V5‐6 (OR 2.08 [1.31–3.29]) significantly predicted NSTE‐ACS. Conclusions: RBBB, S1S2S3, or S1Q3T3 pattern described as characteristic for APE were not helpful in the differentiation between APE and NSTE‐ACS in studied group. Coexistence of negative T waves in precordial leads V1‐3 and inferior wall leads may suggest APE diagnosis. Ann Noninvasive Electrocardiol 2010;15(2):145–150